王红丽,金 磊,沈鑫鑫.Vasohibin-1蛋白在乳腺癌组织中的表达及意义[J].肿瘤学杂志,2021,27(8):649-653.
Vasohibin-1蛋白在乳腺癌组织中的表达及意义
Expression of Vasohibin-1 Protein in Breast Cancer and Its Clinical Significance
投稿时间:2020-08-24  
DOI:10.11735/j.issn.1671-170X.2021.08.B008
中文关键词:  血管抑制蛋白-1  乳腺肿瘤  预后
英文关键词:Vasohibin-1  breast cancer  prognosis
基金项目:新疆维吾尔自治区自然科学基金(2020D01C211)
作者单位
王红丽 新疆医科大学第三临床医学院(附属肿瘤医院) 
金 磊 新疆医科大学第三临床医学院(附属肿瘤医院) 
沈鑫鑫 新疆医科大学第三临床医学院(附属肿瘤医院) 
摘要点击次数: 799
全文下载次数: 164
中文摘要:
      摘 要:[目的] 探讨血管抑制蛋白1(Vasohibin-1,VASH-1)在乳腺组织中表达及其意义。[方法]采用免疫组织化学方法分析Vasohibin-1蛋白在165例原发乳腺癌组织和癌旁组织中表达情况,并分析其表达与临床特征及预后的相关性。[结果] Vasohibin-1在乳腺癌组织、癌旁组织中的阳性表达率分别为51.52%(85/165)、26.06%(43/165),差异有统计学意义(χ2=22.514,P<0.001)。乳腺癌组织中血流丰富区域 Vasohibin-1 阳性表达率高,乏血供区域Vasohibin-1表达率低,两组比较差异有统计学意义(χ2=9.087,P<0.05)。乳腺癌Vasohibin-1阳性表达组5年生存率优于Vasohibin-1阴性表达组,差异有统计学意义(χ2=4.783,P=0.029)。[结论] Vasohibin-1在乳腺癌组织中高表达,特别是在血供丰富的部位,其表达与预后相关。
英文摘要:
      Abstract: [Objective] To investigate the expression of Vasohibin-1(VASH-1) in breast cancer and its clinical significance. [Methods] The expression of Vasohibin-1 in 165 samples of primary breast cancer and adjacent tissues was analyzed by immunohistochemistry, and the correlation between its expression and clinical features and prognosis was analyzed. [Results] The positive expression rate of vasohibin-1 in breast cancer tissues and adjacent tissues was 51.52%(85/165) and 26.06%(43/165), respectively(χ2=22.514, P<0.001).The positive expression rate of vasohibin-1 in breast cancer tissue with rich blood flow was higher than that in areas lack of blood supply(χ2=9.087, P<0.05).The 5-year survival rate of patients with vasohibin-1 positive expression was higher than that of patients with negative expression(χ2=4.783, P=0.029). [Conclusion] Vasohibin-1 is highly expressed in breast cancer tissues, especially in the blood rich sites, and its expression is related to the prognosis.
在线阅读   查看全文  查看/发表评论  下载PDF阅读器